Switching MG Treatment Due to Adverse Events or Poor Disease Control
Expert neurologists share approaches to switching MG treatment due to either poor disease control or adverse events.
Modes of Administration for Targeted Treatment in MG
Experts in neurology review the varied routes of administration of targeted treatment in MG, highlighting intravenous and subcutaneous formulations and how they can provide more patient-centric care.
Use of Targeted Therapies in the Treatment Algorithm of MG
Expert neurologists discuss the treatment algorithm of MG, focusing on the use of targeted therapies as well as barriers to their use.
Targeted Therapy Options in MG
Nicholas Silvestri, MD, FAAN, and Tuan Vu, MD, provide an overview of the current FDA-approved targeted therapies for the treatment of MG.
Quality of Life in MG
Experts in neurology highlight taking age and quality of life into consideration when approaching treatment of MG, as well as comment on the standard of care for patients.
Treatment Approach in MG
Expert neurologists discuss the factors that guide treatment selection in MG, shifting the framework to take patient preferences into account.
Hospitalization of Older Patients in MG
Ali Habib, MD, comments on the prevalence of MG in older patients and the increasing rate of hospitalization and mortality within this group.
Accurate Diagnosis of MG
Beth Stein, MD, reviews critical steps towards diagnosing MG, taking a look at the different types of reliable testing for the disease.
Fatigue and Fluctuating Symptoms in MG
Experts in neurology comment on fatigue and fluctuation of symptoms in MG and how that can contribute to a delay in diagnosis.
Presentation of Myasthenia Gravis (MG)
Expert neurologists discuss the presentation of myasthenia gravis (MG), focusing on the variability of symptoms from patient to patient.
